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Abstract
Purpose—To evaluate cancer incidence among Minnesota Taconite mining workers.
Methods—We evaluated cancer incidence between 1988 and 2010 in a cohort of 40,720 
Minnesota taconite mining workers employed between 1937 and 1983. Standardized incidence 
ratios (SIRs) with 95% confidence intervals (CI) were estimated by comparing numbers of 
incident cancers with frequencies in the Minnesota Cancer Surveillance System. SIRs for lung 
cancer by histological subtypes were also estimated. We adjusted for out-of-state migration and 
conducted a probabilistic bias analysis for smoking related cancers.
Results—A total of 5,700 cancers were identified including 51 mesotheliomas and 973 lung 
cancers. The SIR for lung cancer and mesothelioma were 1.3 (95% CI: 1.2-1.4) and 2.4 (95% CI: 
1.8-3.2) respectively. Stomach, laryngeal, and bladder cancers were also elevated. However, 
adjusting for potential confounding by smoking attenuated the estimates for lung (SIR=1.1, 95% 
CI: 1.0-1.3), laryngeal (SIR=1.2, 95% CI: 0.8-1.6), oral (SIR=0.9, 95% CI: 0.7-1.2), and bladder 
cancers (SIR=1.0, 95% CI: 0.8-1.1).
Conclusions—Taconite workers may have an increased risk for certain cancers. Lifestyle and 
work-related factors may play a role in elevated morbidity. The extent to which mining-related 
exposures contribute to disease burden is being investigated.
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Minnesota's taconite mining industry began in the 1950s in northeastern Minnesota along 
the Mesabi Iron Range, and has grown into an essential part of the states’ economy. The 
industry directly contributes 1.8 billion dollars annually to Minnesota's economy and 
provides thousands of jobs. Today, Minnesota is the largest producer of taconite in the 
United States [1].
Taconite is a low-grade iron ore with a natural iron concentration of roughly 30%. For 
taconite to be commercially useful, its iron is concentrated through processing which 
involves blasting rock with explosives, crushing it into a powder, magnetically extracting 
the iron, and reforming the concentrated product into pellets [2]. This process generates a 
significant amount of dust that results in potential exposure to long and short non-
asbestiform amphibole and non-amphibole elongate mineral particles (EMPs), respirable 
silica, and cleavage fragments [3]. The term ‘EMP’ refers to any mineral particle with a 
minimum aspect ratio of 3:1 that is of inhalable size. Cleavage fragments are mineral EMPs 
that have broken along a cleavage plane during the crushing and fracturing process [4]. 
There have been long standing concerns among workers and community members regarding 
the potential health risks associated with these exposures. Major concerns arose after the 
Minnesota Department of Health reported a 73% excess in cases of mesothelioma among 
men in northeastern Minnesota between 1988 and 1996 [5], suggestive of an occupational 
exposure. Given that the excess in mesothelioma cases occurred in proximity to the Mesabi 
Iron Range, this finding was concerning to the mining industry and contiguous communities.
The association between asbestiform EMP exposure and mesothelioma and lung cancer is 
well documented [4,6-8] however, the carcinogenicity of non-asbestiform EMPs is not 
understood. The National Institute for Occupational Safety and Health (NIOSH) has 
specifically identified non-asbestiform EMPs as a needed area of research [4]. The studies of 
occupational cohorts who experience exposures to non-asbestiform EMPs have been 
inconclusive. Talc miners in upstate New York and gold miners in South Dakota experience 
potential exposures to non-asbestiform EMPs. The studies of talc miners reported an excess 
in mortality from all cancers, lung cancer, ischemic heart disease, and non-malignant 
respiratory disease. Though an exposure-response relationship was seen for NMRD, none 
was observed for lung cancer. [9-11]. Studies of the Homestake gold mine in South Dakota 
reported an excess of respiratory cancer and a small excess of lung cancer [12-14] with no 
observed exposure-response relationship, suggesting a weak association between dust 
exposure and lung cancer. Due to the studies’ limitations, NIOSH has concluded that the 
findings provide inconclusive evidence regarding the health effects associated with 
exposures to non-asbestiform EMPs [4].
Despite community-wide health concerns and the lack of knowledge of the potential health 
effects, there is limited health research related to taconite mining industry workers. Small-
scale mortality studies conducted in the early 1980s and 1990s produced null findings 
[15-17]. These early studies had small study populations, focused on single mining 
companies, and had relatively short follow-up periods. A larger mortality study of the 
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population used for this analysis found an excess of death from lung cancer and 
mesothelioma [18]. This study aims to further characterize the overall health of Minnesota 
taconite mining workers by examining incident cancers in this population.
METHODS
Study population
The study cohort was established in the 1980s by the University of Minnesota and the Iron 
Range Resources and Rehabilitation Board. Investigators assembled a database of 68,737 
individuals who had ever worked in any of the mines in operation in 1983. Work history 
information was collected through 1983, though some individuals worked beyond this point. 
Funding was exhausted before data analysis could be completed.
In 2008, the University of Minnesota launched the Taconite Workers Health Study (TWHS) 
[19]. One objective was to assess the health of the 1983 cohort of 68,737 miners. The cohort 
included both taconite workers and those who had worked in earlier hematite mining 
operations. In order to capture the workers most likely to have been working after taconite 
mining began in the 1950s, the cohort was limited to those born in 1920 or later, reducing 
the cohort to 46,170 individuals. Additional workers were excluded because their only 
record on file was an application with no evidence of employment (n=477), their vital status 
remained unknown after follow-up (n=679), or their employment information was 
improbable, e.g. began working at age fourteen or younger (n=535). For this analysis, the 
cohort was further restricted to individuals living until at least 1988 when the Minnesota 
Cancer Surveillance System would capture the incident cases, which eliminated 3,759 
workers who died before 1988. The final study cohort included 40,720 individuals.
Cancer Incidence
To identify incident cancers, the cohort was linked to the Minnesota Cancer Surveillance 
System (MCSS), the population-based cancer registry that collects histological information 
of newly diagnosed cancers on Minnesota residents. The system was established in 1988 by 
state statute as a mandatory reporting system. Cancer incidence, including date of diagnosis, 
primary cancer site, and histology were obtained for cohort members matched to the MCSS. 
Cancers in the registry are coded according to International Classification of Diseases for 
Oncology current at the time of diagnosis. Estimated completeness of the MCSS is 99.7 
percent and overall accuracy is 96.5 percent [20].
Data analysis
The cancer incidence analysis covered the period from 1988 (when the MCSS began 
collecting data) through 2010. The cancer rate of the cohort was compared with that of the 
Minnesota population to estimate standardized cancer incidence ratios (SIRs) and 95% 
confidence intervals (CIs) adjusted for sex, five-year age, and five-year calendar period. 
Person-time at risk was accrued from January 1, 1988 until diagnosis date, date of death, or 
the end of the follow-up period (December 31, 2010). Individuals with more than one 
diagnosis of the same cancer were followed only to the date of first diagnosis. Those with 
multiple primary cancers were followed until each cancer diagnosis date. The expected 
Allen et al. Page 3













number of cancers was calculated by applying age, calendar time, and sex specific cancer 
rates of the Minnesota population to the person-year observations of the study population. 
The MCSS only reports cancer cases in Minnesota residents, thus a valid estimation of 
incidence required adjusting for out-of-state migration. We used the age group specific 
proportions of out-of-state deaths ascertained in a previously published mortality study [18] 
as an estimate of out-of-state migration in the study population. The proportion of in-state 
deaths by age group was used as an estimate of the proportion of workers who stayed in 
Minnesota to directly adjust the person-years by age-group for rate calculation.
SIRs were obtained by computing the ratio of the observed-to-expected number of cancers. 
The selected cancers, for which SIRs were computed, were mesothelioma, lung, esophageal, 
kidney, laryngeal, liver and bile duct, oral, pancreatic, stomach, and bladder cancers. These 
cancers were of interest to study investigators because of their established association with 
asbestos exposure [4, 21, 22]. All SIRs were computed using STATA 12.1 software.
To explore lung cancer incidence by histological type, lung cancers were grouped into one 
of five subtypes: adenocarcinoma, squamous cell, small cell, other/rare (including large 
cell), and non-specified carcinomas. The histology code groupings were determined by 
study investigators (Appendix Table A). SIRs and 95% CIs were estimated for each of the 
five histological subtypes.
No information on tobacco smoking was available for cohort members however, because 
some of the cancers of interest (lung, oral, laryngeal, and bladder) are strongly associated 
with smoking [23, 24], we conducted a probabilistic bias analysis to adjust for smoking as 
an unmeasured confounder. As part of the TWHS, a subset of 1,313 taconite mining industry 
workers participated in a cross-sectional survey which included a questionnaire with 
smoking history. Roughly 75% of these individuals were also in the study cohort. Details of 
this study can be found elsewhere [25]. The smoking prevalence in this subset was used as 
an estimate of the smoking prevalence in the target population. We used Minnesota 
Behavioral Risk Factor Surveillance System (BRFSS) [26] data weighted by age and sex to 
resemble the taconite survey participants to estimate smoking prevalence in the reference 
population. Based on the probabilistic bias analysis outlined by Lash et al, 2009 [26], we 
assigned a trapezoidal distribution for each of the three bias parameters: smoking prevalence 
among taconite workers, smoking prevalence among the Minnesota population, and cancer 
rates in smokers versus non-smokers. We centered the modes approximately on the values 
identified for each bias parameter, chose a reasonable range for the mode, then extended the 
distribution such that the width of the trapezoid was approximately twice the range between 
modes. Using the software accompanying Lash et al, 2009, [27] we randomly sampled from 
the distribution of each bias parameter and used those values to create corrected effect 
estimates. We repeated this simulation 1,000 times and summarized the results. This 
approach considers the variability in smoking prevalence with a final adjusted estimate to 
compare to the unadjusted estimate. We conducted this bias analysis for four of the smoking 
related cancers (lung, laryngeal, oral, and bladder cancers). The bias parameter distributions 
are summarized in Table 1.
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The study cohort was predominantly male (93%) and worked an average of 6.5 years. 
Among the 40,720 workers, 5,700 cancers were identified by MCSS (5408 for men and 292 
for women). Of those, 973 lung cancers and 51 mesotheliomas were identified. 
Characteristics of the study cohort are described in Table 2.
Adjusting for age, sex, calendar period, and out-of-state migration, the cohort members 
experienced elevated rates of mesothelioma (SIR = 2.4, 95% CI: 1.8-3.2), lung (SIR = 1.3, 
95% CI: 1.2-1.4), laryngeal (SIR = 1.4, 95% CI: 1.1-1.7), stomach (SIR = 1.4, 95% CI: 
1.1-1.6), and bladder (SIR = 1.1, 95% CI: 1.0-1.2) cancers. SIRs and 95% CIs for selected 
cancers are summarized in Table 3.
Among the 973 incident lung cancers, there were 313 adenocarcinomas, 260 squamous cell 
carcinomas, 138 small cell carcinomas, 201 non-specified lung cancers, and 61 other or rare 
types of lung cancer. SIRs were elevated for adenocarcinoma (SIR = 1.2, 95% CI: 1.1-1.4), 
squamous cell (SIR = 1.3, 95% CI: 1.2-1.5), non-specified (SIR = 1.6, 95% CI: 1.3-1.8), and 
rare cancers (SIR = 1.3, 95% CI: 1.0-1.7) after adjusting for age, sex, calendar period, and 
out-of-state migration (Table 4).
Questionnaire data taken from the subset of miners who participated in the survey study 
were summarized into ever and never smokers. Among the 1,313 current and former 
taconite workers, 38.2% were considered never smokers, compared to 50.1% of the 
reference population. Cancer rates in smokers versus non-smokers obtained from World 
Health Organization estimates were: for lung cancer 10, for oral cancer, 27, for laryngeal 
cancer, 12, and for bladder cancer, 3 [23]. After probabilistic adjustment for smoking, rates 
of laryngeal, oral, and bladder cancers in the taconite population were similar to what is 
expected in Minnesota (laryngeal SIR = 1.2, 95% CI: 0.8-1.6; oral SIR = 0.9, 95% CI: 
0.7-1.2; bladder SIR = 1.0, 95% CI: 0.8-1.1). SIR for lung cancer was also attenuated, but 
still elevated (lung SIR = 1.1, 95% CI: 1.0-1.3). Though the effect of smoking on lung 
cancer risk varies by histological subtype, squamous and small cell carcinomas are found to 
be the most strongly associated [28]. After probabilistic adjustment, the SIRs were 
attenuated to what would be expected in Minnesota for both squamous (SIR = 1.1, 95% CI: 
0.9-1.2) and small cell carcinoma (SIR = 0.9, 95% CI: 0.8-1.1). These results are 
summarized in Table 5.
DISCUSSION
In this analysis there were higher than expected rates of certain cancers as compared to the 
Minnesota population, specifically for mesothelioma, lung, laryngeal, stomach, and bladder 
cancers. Lung cancer by histological subtype showed an increased SIR. A sensitivity 
analysis to account for differences in smoking rates between the study and reference 
populations suggested that an association between taconite work and lung, laryngeal, 
bladder, and oral cancers as well as squamous cell and small cell carcinomas of the lung is 
small if not absent. Restricting the cohort to those with at least 1 year of employment did not 
substantially change the results.
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Cancer incidence has not been previously examined in this population. Early studies of 
taconite mining exposures focused on ingestion and showed no association between cancers 
and EMP ingestion [29, 30]. These were followed by mortality assessments [15-17]. Though 
these mortality studies did not show an excess in respiratory cancers, they had small study 
populations, short follow-up periods and thus limited statistical power. The most recent 
study of this population reported an excess in mortality from mesothelioma and lung cancer 
[18]. In 2007, the Minnesota Department of Health reported a 73% excess in cases of 
mesothelioma for men in northeastern Minnesota between 1988 and 1996 [5], consistent 
with the elevated SIR reported here. The cause of this excess remains unknown.
Several studies have examined the risk of exposure to non-asbestiform EMPs [9, 10, 12-14], 
but the toxicity of these exposures is uncertain [4]. A limited number of animal studies in 
this field suggested that non-asbestiform amphiboles might pose different risks than asbestos 
[31-33], but that risk remains unclear [4]. Crystalline silica is classified as a known human 
lung carcinogen by the International Agency for Research on Cancer [34]. In a 2010 subset 
analysis of approximately 1,200 workers, 5-6% had a chest x-rays consistent with 
pneumoconiosis [35].
As in most occupational epidemiology studies that utilize historical employment records, we 
did not have data on personal risk factors that might confound the results. In this case, we 
had no information on smoking habits of the study population, the major risk factor for lung 
cancer and many other cancers in our analysis. A difference in smoking habit between the 
taconite workers and the general Minnesota population is likely given the documented 
higher rates of smoking in working cohorts [36]. However, subject-specific data on 
confounders are not necessarily needed to evaluate potential confounding [37]. Without 
direct measures of smoking information for cohort members, we conducted an indirect 
adjustment, a method shown to be effective in estimating bias associated with unmeasured 
confounders in occupational studies [37, 38]. One such method is to estimate hypothetical 
smoking habits using available records from a subset or similar population [39]. Using a 
probabilistic bias analysis, we adjusted our point estimates to account for smoking as an 
unmeasured confounder, a method that incorporates systematic and random error and 
uncertainty in the adjustment [27].
Some limitations should be considered when interpreting these results. Utilizing the 
Minnesota state cancer registry data requires cohort members to remain in Minnesota in 
order to capture newly diagnosed cancers. Because it was not feasible to identify if an 
individual was diagnosed with cancer outside of Minnesota, adjustments in person-years 
were required to correct for potential underestimation of SIRs. We used out-of-state deaths 
by age group as an estimate of the proportion of individuals in each age group who left 
Minnesota. The MCSS was not in operation prior to 1988, thus the analysis was based on 
the cohort members who survived until that year. Among those who died before 1988 and 
thus were excluded from this analysis, we observed 747 deaths from cancer, including 
cancer of the lung (n=261), esophagus (n=22), kidney (n=25), larynx (n=10), liver & bile 
duct (n=13), pancreas (n=40), stomach (n=24), and bladder (n=12). Prior to 1988, 
mesothelioma did not have a specific ICD code and was thus not identified. To the extent 
these cases were related to mining exposures, the estimated SIRs could have been biased 
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toward the null, analogous to the healthy worker effect which can result in attenuated 
estimates. [40]
Though the bias analysis used is an accepted method for adjusting for unmeasured 
confounding in occupational studies, there are potential limitations using the subset of 
miners as an estimate of smoking habits in our study population. Differences in past 
smoking habits, at a point in time prior to disease incidence, are most critical however, the 
subset analysis from which smoking data was collected was done in 2010, the end of the 
follow-up period. Those who participated in the subset analysis thus may have very different 
smoking habits than their historic counterparts due to generational differences in smoking 
patterns. Furthermore, comparing recent smoking prevalence data in the exposed cohort with 
smoking prevalence in the non-exposed referent group excludes the majority of cohort 
members who died during the follow up period. Focusing on survivors runs the risk of 
underestimating the cohort's smoking prevalence, given that decedents are likely to have 
smoked more than survivors [41]. However, because smoking habits for the reference 
population were taken from BRFSS 2010 data, the relative differences in smoking between 
the two groups were taken at the same time. We assumed that population and cohort 
smoking rates changed at the same rate. Thus the bias factor analysis accounted for this 
relative difference in smoking and adjusted the SIRs accordingly. We were unable to 
examine an interaction with smoking using this bias analysis. The sensitivity analysis also 
required knowing the cancer rate in smokers versus non-smokers. This estimation can vary 
among different sources [23, 38] however changing this variable in the probabilistic bias 
calculation did not substantially change the results of the sensitivity analysis.
One of the main strengths of this study is the large size of the cohort. The study population 
included all taconite mining industry workers with any work experience across the entire 
Mesabi Iron Range with very few workers (4%) excluded from the analysis due to data 
quality problems. Having mortality data including state of death for the study population 
allowed for an estimation of out-of-state migration which can be challenging for other 
cancer incidence studies of this nature.
CONCLUSIONS
This analysis provides some evidence that Minnesota taconite mining workers are at higher 
risk for mesothelioma, and other cancers. The sensitivity analysis we conducted indicates 
the elevated risk of some cancers may be a consequence of smoking and other unmeasured 
confounders. However, because confounding variables were not measured in the study 
population and workplace exposures include known carcinogens, it is possible that 
workplace exposures contribute to the excess in cancer incidence.
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Lung Cancer Major Histology Groupings
Histology ICD-O code count
ADENOCARCINOMA 313
    Acinic Cell Adenocarcinoma 85503 1
    Adenocarcinoma NOS 81403 263
    Bronchiolo-Alveolar Adenocarcinoma 82503 23
    Bronchiolo-Alveolar Mucinous 82533 1
    Bronchiolo-Alveolar non-mucinous 82523 4
    Mixed Cell Adenocarcinoma 83233 1
    Mucin Producing Adenocarcinoma 84813 11
    Clear Cell Adenocarcinoma 83103 1
    Mucinous Adenocarcinoma 84803 5
    Papillary Adenocarcinoma NOS 82603 3
SMALL CELL CARCINOMA 139
    Combined Small Cell Carcinoma 80453 2
    Intermediate Cell Small Cell Carcinoma 80443 5
    Neuroendocrine Carcinoma 82463 9
    Oat Cell Carcinoma 80423 4
    Small Cell Tumor 80023 1
    Small Cell Carcinoma NOS 80413 118
SQUAMOUS CELL CARCINOMA 258
    Basaloid Squamous Cell Carcinoma 80833 1
    Squamous Cell Carcinoma Spindle Cell 80743 1
    Squamous Cell Carcinoma Keratinizing 80713 9
    Squamous Cell Carcinoma Non-Keratinizing 80723 10
    Squamous Cell Carcinoma 80703 237
NON-SPECIFIED 202
    Neoplasm Malignant 80003 19
    Non-Small Cell Carcinoma 80463 97
    Carcinoma NOS 80103 68
    Undifferentiated Carcinoma 80203 11
    Carcinoid Tumor 82403 4
    Atypical Carcinoid Tumor 82493 1
    Tumor cells Malignant 80013 2
RARE/OTHER 61
    Anaplastic Carcinoma 80213 2
    Spindle Cell Carcinoma 80323 1
    Large Cell Carcinoma NOS 80123 38
    Large Cell Carcinoma rhabdoidphenotype 80143 1
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Histology ICD-O code count
    Adenosquamous Carcinoma 85603 12
    Fibrous histiocytoma 88303 1
    Large Cell Neuroendocrine Carcinoma 80133 5
    Sarcome NOS 88003 1
LIST OF ABBREVIATIONS
BRFSS Behavioral Risk Factor Surveillance system
CI Confidence Interval
EMP Elongate mineral particle
ICD-O International Classification of Diseases for Oncology
MCSS Minnesota Cancer Surveillance System
NIOSH National Institute for Occupational Safety and Health
SIR Standardized Cancer Incidence Ratio
TWHS Taconite Workers Health Study
WHO World Health Organization
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Table 1
Parameter Distributions for Probabilistic Bias Analysis of Taconite Exposures and Cancer Stratified by 
Smoking as an Unmeasured Confounder.
Bias parameter Minimum Lower Mode Upper Mode Maximum
Smoking prevalence among taconite workers
a 0.52 0.57 0.67 0.72
Smoking prevalence among Minnesota population
b 0.40 0.45 0.55 0.60
Cancer rate in smokers versus non-smokers
c
    Lung 8 9 11 12
    Larynx 10 11 13 14
    Oral 25 26 28 29
    Bladder 1.1 2 4 5
a
Estimated from Taconite Workers Health Study survey [19]
b
Estimated from Minnesota BRFSS data [22]
c
Estimated from WHO [25]
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Table 2




    < 1 11994 29.45
    1-5 14206 34.89
    6-14 8445 20.74
    15+ 6075 14.92
SEX
    Male 37755 92.72
    Female 2953 7.25
    Unknown 12 0.03
AGE AT HIRE
    < 20 14899 36.56
    20-29 21708 53.31
    30-39 3417 8.39
    40+ 706 1.73
DECADE OF HIRE
    < 1950 5190 12.75
    1950 to 1959 12075 29.65
    1960 to 1969 9407 23.10
    1970 to 1979 13384 32.87
    > 1980 664 1.63
DECADE OF BIRTH
    < 1930 9976 24.50
    1930 to 1939 9961 24.46
    1940 to 1949 9332 22.92
    1959-1959 10759 26.42
    > 1959 692 1.70
TOTAL 40720 100.0
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Table 3
Selected Standardized Incidence Ratios of Cancer in Minnesota Taconite Workers
Cancer Observed Expected SIR 95% CI
Mesothelioma 51 21.1 2.4 1.8, 3.2
Lung 973 750.9 1.3 1.2, 1.4
Esophagus 87 76.9 1.1 0.9, 1.4
Kidney 170 178.2 1.0 0.8, 1.1
Larynx 94 68.6 1.4 1.1, 1.7
Liver & bile duct 52 49.4 1.1 0.8, 1.4
Oral 172 162.5 1.1 0.9, 1.2
Pancreas 120 105.9 1.1 0.9, 1.4
Stomach 105 77.7 1.4 1.1, 1.6
Bladder 363 338.5 1.1 1.0, 1.2
aAdjusted for age, sex, calendar period, and out-of-state migration
SIR = Standardized incidence ratio
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Table 4
Standardized Incidence Ratios of Cancer for Lung Cancer by Histological Subtype
Lung cancer histological subtype N SIR 95% CI
Adenocarcinoma 313 1.2 1.1, 1.4
Squamous cell 260 1.3 1.2, 1.5
Small Cell 138 1.1 1.0, 1.3
Non-specified 201 1.6 1.3, 1.8
Rare/other (including large cell) 61 1.3 1.0, 1.7
Total 973 1.3 1.2, 1.4
aAdjusted for age, sex, calendar period, and out-of-state migration
SIR = Standardized incidence ratio
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Table 5
Standardized Incidence Ratios of Cancer for Smoking Related Cancers Before and After Probabilistic Bias 
Adjustment for Smoking
Cancer SIR
a 95% CI Adjusted SIR
a,b 95% CI
Lung 1.3 1.2, 1.4 1.1 1.0, 1.3
    Squamous cell 1.3 1.2, 1.5 1.1 0.9, 1.3
    Small cell 1.1 1.0, 1.3 1.0 0.7, 1.2
Larynx 1.4 1.1, 1.7 1.2 0.8, 1.6
Oral 1.1 0.9, 1.2 0.9 0.7, 1.2
Bladder 1.1 1.0, 1.2 1.0 0.8, 1.1
a
Adjusted for age, sex, calendar period, and out-of-state migration
b
Adjusted for smoking using probabilistic bias adjustment for unmeasured confounder SIR = Standardized incidence ratio
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